Sign In
Buy OMER
$10.16
-0.1000 (-0.97%)
At Close: Jun 03, 2026
Omeros Q1 Earnings Call Highlights
12:15am, Thursday, 14'th May 2026
Omeros NASDAQ: OMER reported first-quarter 2026 net income of $56.1 million, or $0.78 per share, as the company began commercial sales of YARTEMLEA, its recently approved treatment for hematopoietic s
Omeros Corporation (OMER) Q1 2026 Earnings Call Transcript
11:20pm, Wednesday, 13'th May 2026
Omeros Corporation (OMER) Q1 2026 Earnings Call Transcript
Omeros Corporation Reports First Quarter 2026 Financial Results
04:02pm, Wednesday, 13'th May 2026
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced recent highlights and developments as well as financial results for the first quarter ended March 31, 2026, which include: F
Omeros Corporation to Announce First Quarter Financial Results on May 13, 2026
04:02pm, Monday, 11'th May 2026
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER) today announced that it will issue its financial results for the first quarter 2026 on Wednesday, May 13, 2026 after market close. Omeros ma
Here's Why Omeros (OMER) is a Great Momentum Stock to Buy
01:02pm, Monday, 27'th Apr 2026
Does Omeros (OMER) have what it takes to be a top stock pick for momentum investors? Let's find out.
Wall Street Analysts Believe Omeros (OMER) Could Rally 222.76%: Here's is How to Trade
10:55am, Monday, 27'th Apr 2026
The consensus price target hints at a 222.8% upside potential for Omeros (OMER). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate
4 Medical Product Stocks to Buy From a Challenging Industry
09:31am, Monday, 27'th Apr 2026
The Zacks Medical - Products industry faces macro headwinds, keeping growth under pressure in 2026, but steady demand may continue. PAHC, BLFS, OMER and BWAY reflect the favorable fundamentals.
CMS Assigns Permanent Reimbursement J-Code for YARTEMLEA® (narsoplimab-wuug)
08:45am, Thursday, 16'th Apr 2026
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Centers for Medicare & Medicaid Services (CMS) has assigned a permanent Healthcare Common Procedure Coding Sys
Omeros Corporation (NASDAQ:OMER) Given Average Recommendation of “Moderate Buy” by Brokerages
03:20am, Sunday, 12'th Apr 2026
Omeros Corporation (NASDAQ: OMER - Get Free Report) has been given a consensus rating of "Moderate Buy" by the six brokerages that are covering the firm, MarketBeat.com reports. One research analyst h
Does Omeros (OMER) Have the Potential to Rally 266.67% as Wall Street Analysts Expect?
10:56am, Friday, 10'th Apr 2026
The average of price targets set by Wall Street analysts indicates a potential upside of 266.7% in Omeros (OMER). While the effectiveness of this highly sought-after metric is questionable, the positi
JPMorgan Chase & Co. Boosts Holdings in Omeros Corporation $OMER
04:44am, Wednesday, 08'th Apr 2026
JPMorgan Chase and Co. grew its position in Omeros Corporation (NASDAQ: OMER) by 1,201.1% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Excha
Contrasting Omeros (NASDAQ:OMER) and Medtronic (NYSE:MDT)
02:02am, Monday, 06'th Apr 2026
Medtronic (NYSE: MDT - Get Free Report) and Omeros (NASDAQ: OMER - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the st
Omeros: Making The Bull Case On Q4 Earnings, Ahead Of Key Q1 Commercial Updates
11:21am, Thursday, 02'nd Apr 2026
Omeros Corporation maintains a Buy rating, driven by Yartemlea's FDA approval for TA-TMA and the Novo Nordisk zaltenibart deal. OMER's 2025 net loss narrowed to $(3.35m) due to a $237.6m gain on zalte
Stock Traders Buy High Volume of Call Options on Omeros (NASDAQ:OMER)
01:28am, Thursday, 02'nd Apr 2026
Omeros Corporation (NASDAQ: OMER - Get Free Report) saw some unusual options trading activity on Wednesday. Stock traders purchased 7,487 call options on the company. This represents an increase of ap
Omeros Corporation (OMER) Q4 2025 Earnings Call Transcript
03:52am, Wednesday, 01'st Apr 2026
Omeros Corporation (OMER) Q4 2025 Earnings Call Transcript
